Skip to main content

Series B Biopharma Companies

Explore 92 biopharma startups that raised series b funding. Access verified founder contact information and fundraising data.

Total Companies
92
Total Funding
$1.7B
Avg Funding
$67.1M
Cities
22

Export 92 Series B Biopharma Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
London, United Kingdom
$16.3M
raised

Epsilogen is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.

Sep 2024
Series B

Founder Contacts

41,000+ verified contacts

Melbourne, Australia
$14.5M
raised

OccuRx is a biopharmaceutical company that focuses on the development of innovative therapeutic strategies.

Sep 2022
Series B

Founder Contacts

41,000+ verified contacts

Sandwich, United Kingdom
$47.8M
raised

Levicept develops biological agent for the treatment of chronic pain.

Sep 2021
Series B

Founder Contacts

41,000+ verified contacts

Los Angeles, United States
$30.0M
raised

PictorLabs offers virtual staining technology using proprietary models powered by artificial intelligence.

Sep 2024
Series B

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$43.5M
raised

Novome Biotechnologies is a biotechnology company focused on engineering defined activities into the human.

Sep 2022
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 92 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Cambridge, United Kingdom
$12.0M
raised

PhoreMost is a new-model drug discovery company based in Cambridge, UK.

Sep 2024
Series B

Founder Contacts

41,000+ verified contacts

Hanover, Germany
$75.3M
raised

Cardior Pharmaceuticals discovers and develops medicines and therapeutics for the treatment and prevention of heart disease.

Aug 2021
Series B

Founder Contacts

41,000+ verified contacts

Raleigh, United States
$105.0M
raised

Pathalys is a clinical biopharmaceutical company that develops therapeutics that improve late-stage chronic kidney disease.

Aug 2024
Series B

Founder Contacts

41,000+ verified contacts

Richmond, United States
$150.0M
raised

Your premier CDMO for biologics drug development and manufacturing, from early development, to IND, to commercial stage.

Aug 2021
Series B

Founder Contacts

41,000+ verified contacts

Hørsholm, Denmark
$11.7M
raised

Biosyntia is a biotech startup within synthetic biology and metabolic engineering.

Jul 2022
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 92 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Jersey City, United States
$118.0M
raised

Claris Biotherapeutics develops biologic therapies for corneal diseases and other disorders affecting the ocular surface.

Jul 2026
Series B

Founder Contacts

41,000+ verified contacts

San Diego, United States
$130.0M
raised

Crystalys Therapeutics is a clinical-stage biopharmaceutical company that develops targeted therapies for gout and hyperuricemia.

Jul 2026
Series B

Founder Contacts

41,000+ verified contacts

Cardiff, United Kingdom
$65.0M
raised

Draig Therapeutics is a clinical-stage biopharmaceutical company that develops investigational therapies for neuropsychiatric disorders.

Jul 2026
Series B

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$99.5M
raised

City Therapeutics is a biopharmaceutical company focused on developing RNA interference (RNAi)-based medicines for a range of diseases.

Jun 2026
Series B

Founder Contacts

41,000+ verified contacts

Oakland, United States
$62.0M
raised

Oblenio Bio is a biotechnology company that develops T-cell engager therapeutic candidates for autoimmune disease treatment.

Jun 2026
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 92 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Austin, United States
$330.0M
raised

Ollin Biosciences develops ophthalmic therapies focused on treating serious vision-threatening diseases.

Jun 2026
Series B

Founder Contacts

41,000+ verified contacts

Tours, France
$1.1M
raised

ABC Transfer is a biopharmaceutical company that develops Rapid Transfer Systems (RTS) solutions.

Jun 2022
Series B

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$125.0M
raised

SonoThera develops ultrasound-based technologies for delivering genetic therapies to targeted tissues.

Jun 2026
Series B

Founder Contacts

41,000+ verified contacts

$6.2M
raised

AceRNA Technologies is a biotech startup that develops patient-centric genetic therapies with RNA switch technology for drug discovery.

May 2024
Series B

Founder Contacts

41,000+ verified contacts

Morrisville, United States
$35.0M
raised

Locus Biosciences develops CRISPR-engineered precision antibacterial platform designed to revolutionize the treatment of bacterial disease.

May 2022
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 92 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Los Angeles, United States
$712K
raised

Bionaut Labs revolutionizes the treatment of central nervous system disorders with its precision medicine treatment modality.

May 2024
Series B

Founder Contacts

41,000+ verified contacts

$38.0M
raised

NVision Imaging Technologies develops quantum-based medical imaging technology that enhances the capabilities of standard MRI systems.

May 2026
Series B

Founder Contacts

41,000+ verified contacts

Boston, United States
$60.5M
raised

Invetx is a veterinary therapeutics company that develops protein-based therapeutics for the treatment of various animal diseases.

May 2022
Series B

Founder Contacts

41,000+ verified contacts

Houston, United States
$25.0M
raised

Stramsen Biotech is a biopharmaceutical company that uses natural plant based approach to develop medicines.

Apr 2025
Series B

Founder Contacts

41,000+ verified contacts

Dublin, Ireland
$76.0M
raised

Juvenescence is a biotech company that develops therapies and products to modify aging and help people live longer.

Apr 2025
Series B

Founder Contacts

41,000+ verified contacts

Showing 1 to 25 of 92 companies

Ready to Connect with Series B Biopharma Startups?

Get verified founder emails, funding details, and company data for 92 series b biopharma companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked